What is the primary pathophysiology of Immune Thrombocytopenic Purpura (ITP)?

What is the primary pathophysiology of Immune Thrombocytopenic Purpura (ITP)?

• A. Autoimmune antibodies bind to platelets, leading to their destruction
• B. Autoimmune antibodies attack red blood cells
• C. Platelets are produced in excess
• D. Clotting factor VIII deficiency

Answer: (A)

ITP mainly comes from autoantibody-mediated destruction of platelets. Autoantibodies, often IgG, target platelet surface glycoproteins (such as GPIIb/IIIa or GPIb-IX-V), causing platelets to be marked for clearance by splenic macrophages. This leads to a reduced circulating platelet count and the bleeding symptoms you see clinically. While there can be some suppression of platelet production in the marrow due to autoantibodies against megakaryocytes, the dominant issue is increased peripheral destruction. This distinguishes it from conditions where red blood cells are targeted (autoimmune hemolytic processes) or where coagulation factors (like factor VIII) are deficient, which affect different parts of hemostasis.

ITP mainly comes from autoantibody-mediated destruction of platelets. Autoantibodies, often IgG, target platelet surface glycoproteins (such as GPIIb/IIIa or GPIb-IX-V), causing platelets to be marked for clearance by splenic macrophages. This leads to a reduced circulating platelet count and the bleeding symptoms you see clinically. While there can be some suppression of platelet production in the marrow due to autoantibodies against megakaryocytes, the dominant issue is increased peripheral destruction. This distinguishes it from conditions where red blood cells are targeted (autoimmune hemolytic processes) or where coagulation factors (like factor VIII) are deficient, which affect different parts of hemostasis.